Life sciences and healthcare investor Abingworth has held a final close for Abingworth Bioventures VI on £225m, exceeding its £200m target.
Noerr’s Holger Ebersberger and Latham & Watkins’ Hanno Witt to join the firm’s Munich office
London-headquartered GP invested in AI provider MIcompany in first deal for new strategy this week
VC firm aims to raise USD 75m-150m from private and public investors including blue-chip institutional LPs in Europe, MENA and US
More than twice the size of its 2019 predecessor, the vehicle will allow for larger equity tickets, more investments and bolt-ons